More on RHHBY
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $53.09 |
|
|||
| Open | $53.94 | ||||
| 52 Wk High | $35.13 | ||||
| 52 Wk Low | $28.10 | ||||
| Day High | $54.28 | ||||
| Day Low | $53.59 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,758,699 | ||||
- Roche wins FDA nod for HER2 companion diagnostics in GEA
- Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
- Flatiron Health Expands NSCLC Panoramic Dataset With Comprehensive Biomarker Data Model, Enabling Precision Medicine Research at Unprecedented Scale
- Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care
- Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
- Genentech Marks Topping out Milestone for New Holly Springs, North Carolina Manufacturing Facility
- Morgan Stanley Upgrades Roche (RHHBY) to Overweight
- Morgan Stanley Upgrades Roche Holding (ROG:SW) (RHHBY) to Overweight
- Roche expands cyclospora testing portfolio to support U.S. public health response
- Buy this biotech stock into Q2 earnings: Analyst
Entities mentioned with RHHBY
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Industrial Production | View Related Stories »
- Show More...
